This one-day workshop, sponsored by the American Institute for Medical and Biological Engineering, will focus on the challenges of moving advanced technologies from the academic lab to the marketplace. The event will convene various groups involved in this process to collaboratively identify and address key gaps. Attendees will:
- Discuss the early incorporation of evolving regulatory and policy requirements into leading-edge research.
- Formulate improved pathways and policies for medical innovation.
- Design a comprehensive roadmap to market.
Participants will include academic researchers and administrators, entrepreneurs, industry leaders, regulatory and policy representatives, investors, and funding agency officers.
Organized by AIMBE Fellows Drs. Karen Burg and Crystal Leach.
Workshop Steering Committee:
- Karen Burg (Committee Co‐Chair), University of Georgia
- Crystal Leach (Committee Co‐Chair), University of Georgia
- Tiffany Wilson (Committee Co‐Chair), Global Center for Medical Innovation
- Dorothy Abel, US Food and Drug Administration
- Taby Ahsan, RoosterBio Inc.
- Thomas Boland, University of Texas, El Paso
- Elizabeth Dougherty, U.S. Patent and Trademark Office
- Cartier Esham, Biotechnology Innovation Organization
- Iris Marklein, University of Georgia
- Todd Merchak, National Institute of Biomedical Imaging and Bioengineering
- Kyle Siegal, Skysong Innovations
- Šeila Selimović, National Institute of Biomedical Imaging and Bioengineering
- TG Venkateshwaren, Merck & Company, Inc.
- Phil Weilerstein, VentureWell
Contact Sarah Mandell, American Institute for Medical and Biological Engineering, at firstname.lastname@example.org for more information.